Tsuyoshi Fujita to Pancreatic Ducts
This is a "connection" page, showing publications Tsuyoshi Fujita has written about Pancreatic Ducts.
Connection Strength
0.213
-
Takenaka M, Fujita T, Sugiyama D, Masuda A, Shiomi H, Sugimoto M, Sanuki T, Hayakumo T, Azuma T, Kutsumi H. What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis. J Hepatobiliary Pancreat Sci. 2014 Apr; 21(4):275-80.
Score: 0.104
-
Fukuba N, Fujita K, Nakayama S, Takenaka M, Matsui S, Ozaka M, Shibagaki K, Yoshinaga H, Masuzawa A, Watanabe A, Fujiwara H, Sugahara A, Fujita T, Mukai H, Tsukamoto T, Teramura K. [A case of small pancreatic cancer with intraductal progress]. Nihon Shokakibyo Gakkai Zasshi. 2010 May; 107(5):792-7.
Score: 0.083
-
Masuda A, Arisaka Y, Hara S, Matsumoto I, Takenaka M, Sakai A, Shiomi H, Matsuki N, Sugimoto M, Fujita T, Hayakumo T, Ku Y, Ogino S, Azuma T, Kutsumi H. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2013 Nov-Dec; 13(6):583-8.
Score: 0.026